Hydrogen Sulfide and Substance P Levels in Patients with Escherichia coli and Klebsiella pneumoniae Bacteraemia

被引:4
|
作者
Manandhar, Sumeet [1 ]
Scott-Thomas, Amy [1 ]
Harrington, Michael [2 ]
Sinha, Priyanka [1 ]
Pilbrow, Anna [3 ]
Richards, Arthur Mark [3 ]
Cameron, Vicky [3 ]
Bhatia, Madhav [1 ]
Chambers, Stephen T. [1 ]
机构
[1] Univ Otago, Dept Pathol & Biomed Sci, Christchurch 8140, New Zealand
[2] Canterbury Hlth Labs, Microbiol Dept, Christchurch 8140, New Zealand
[3] Univ Otago, Dept Med, Christchurch 8140, New Zealand
关键词
hydrogen sulfide; substance P; sepsis; Escherichia coli; Klebsiella pneumoniae; C-REACTIVE PROTEIN; PUNCTURE-INDUCED SEPSIS; CECAL LIGATION; LUNG INJURY; PLASMA-CONCENTRATIONS; CIRCULATING LEVELS; GENE-PRODUCTS; PREPROTACHYKININ; INTERLEUKIN-6; INFLAMMATION;
D O I
10.3390/ijms23158639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen sulfide (H2S) and substance P (SP) are known from animal models and in vitro studies as proinflammatory mediators. In this study, peripheral blood concentrations of H2S and SP were measured in patients with Escherichia coli or Klebsiella pneumoniae bacteraemia. Fifty patients were recruited from general wards at Christchurch Hospital, during 2020-2021. Samples from age- and sex-matched healthy subjects previously recruited as controls for studies of cardiovascular disease were used as controls. The concentrations of H2S were higher than controls on day 0, day 1, and day 2, and SP was higher than controls on all 4 days. The concentrations of H2S were highest on day 0, whereas SP concentrations were higher on day 2 than other days. Interleukin-6 and C-reactive protein were significantly higher on day 0 and day 1, respectively. The concentrations of H2S and SP did not differ between 15 non-septic (SIRS 0-1) and the 35 septic subjects (SIRS >= 2). Substance P concentrations were higher in subjects with abdominal infection than urinary tract infections on day 0 (p = 0.0002) and day 1 (p = 0.0091). In conclusion, the peak H2S concentrations precede the SP peak in patients with Gram-negative bacteraemia, but this response varies with the site of infection.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Ceftazidime-avibactam activity against Escherichia coli and Klebsiella pneumoniae
    Sachu, Arun
    David, Alice
    IRANIAN JOURNAL OF MICROBIOLOGY, 2025, 17 (01) : 19 - 24
  • [22] INVESTIGATIONS TO COLONIZE ESCHERICHIA-COLI AND KLEBSIELLA PNEUMONIAE IN THE INTESTINE OF BUDGERIGARS
    GLUNDER, G
    MARTINSEN, LL
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 1981, 94 (16): : 322 - 325
  • [23] The rapid-simple-ESBL test in Escherichia coli and Klebsiella pneumoniae
    Tharavichitkul, P.
    Kaewmalakul, J.
    Khanthawa, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E405 - E405
  • [24] Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis
    Stucki, Armin
    Cottagnoud, Marianne
    Acosta, Fernando
    Egerman, Ueli
    Laeuffer, Joerg M.
    Cottagnoud, Philippe
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (03) : 661 - 665
  • [25] Cobalt complexes modulate plasmid conjugation in Escherichia coli and Klebsiella pneumoniae
    Alav, Ilyas
    Pordelkhaki, Parisa
    de Resende, Pedro Ernesto
    Partington, Hannah
    Gibbons, Simon
    Lord, Rianne M.
    Buckner, Michelle M. C.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [26] AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae
    Roberts, Tamalee
    Ling, Clare L.
    Watthanaworawit, Wanitda
    Cheav, Chanvoleak
    Sengduangphachanh, Amphonesavanh
    Silisouk, Joy
    Hopkins, Jill
    Phommasone, Koukeo
    Batty, Elizabeth M.
    Turner, Paul
    Ashley, Elizabeth A.
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (06):
  • [27] COMPARISON OF THE MALA REGIONS OF ESCHERICHIA-COLI AND KLEBSIELLA-PNEUMONIAE
    BLOCH, MA
    RAIBAUD, O
    JOURNAL OF BACTERIOLOGY, 1986, 168 (03) : 1220 - 1227
  • [29] Time-to-positivity in patients with Escherichia coli bacteraemia
    Peralta, G.
    Roiz, M. P.
    Sanchez, M. B.
    Garrido, J. C.
    Ceballos, B.
    Rodriguez-Lera, M. J.
    Mateos, F.
    De Benito, I.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) : 1077 - 1082
  • [30] Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae
    Luo, Hong
    Xiao, Yanping
    Hang, Yaping
    Chen, Yanhui
    Zhu, Hongying
    Fang, Xueyao
    Cao, Xingwei
    Zou, Shan
    Hu, Xiaoyan
    Xiong, Jianqiu
    Zhong, Qiaoshi
    Hu, Longhua
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)